- Home
- IZM vs CRIS Comparison
IZM vs CRIS Comparison
Compare IZM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- CRIS
- Stock Information
- Founded
- IZM 2011
- CRIS 2000
- Country
- IZM China
- CRIS United States
- Employees
- IZM N/A
- CRIS N/A
- Industry
- IZM Consumer Electronics/Video Chains
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IZM Consumer Discretionary
- CRIS Health Care
- Exchange
- IZM Nasdaq
- CRIS Nasdaq
- Market Cap
- IZM 21.1M
- CRIS 21.3M
- IPO Year
- IZM 2023
- CRIS 2000
- Fundamental
- Price
- IZM $2.39
- CRIS $2.37
- Analyst Decision
- IZM
- CRIS Strong Buy
- Analyst Count
- IZM 0
- CRIS 2
- Target Price
- IZM N/A
- CRIS $16.50
- AVG Volume (30 Days)
- IZM 28.8K
- CRIS 76.2K
- Earning Date
- IZM 07-25-2025
- CRIS 07-31-2025
- Dividend Yield
- IZM N/A
- CRIS N/A
- EPS Growth
- IZM N/A
- CRIS N/A
- EPS
- IZM N/A
- CRIS N/A
- Revenue
- IZM $177,933,890.00
- CRIS $11,202,000.00
- Revenue This Year
- IZM N/A
- CRIS $0.93
- Revenue Next Year
- IZM N/A
- CRIS $8.10
- P/E Ratio
- IZM N/A
- CRIS N/A
- Revenue Growth
- IZM N/A
- CRIS 14.17
- 52 Week Low
- IZM $1.18
- CRIS $1.02
- 52 Week High
- IZM $3.19
- CRIS $9.72
- Technical
- Relative Strength Index (RSI)
- IZM 58.47
- CRIS 59.94
- Support Level
- IZM $2.28
- CRIS $2.23
- Resistance Level
- IZM $2.42
- CRIS $2.63
- Average True Range (ATR)
- IZM 0.11
- CRIS 0.18
- MACD
- IZM -0.03
- CRIS 0.03
- Stochastic Oscillator
- IZM 45.45
- CRIS 67.09
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.